A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults
Status:
Not yet recruiting
Trial end date:
2025-07-31
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the tolerance, and safety of HRS-8080 tablets
monotherapy and combined with other anti-cancer therapy for metastatic or local advanced
breast cancer in adults. To explore the reasonable dosage of HRS-8080 tablets for metastatic
or local advanced breast cancer.